BIVV
Bioverativ Inc
Biotechnology company focused on hemophilia and rare blood disorders
CUSIP: 09075E100HealthcareUS1 holder
Total Value
$461.65M
Total Shares
8.48M
Net Share Change
+8.48M
Activity
1 buying
Investor
Value
Shares
Weight
Change
ValueAct Capital
$461.65M8.48M sharesNEW